Erasmus MC ( Site 5303) — Rotterdam, South Holland

Public research footprint of Erasmus MC ( Site 5303), compiled from the ClinicalTrials.gov public registry.

819

Registered studies

287

Active

160

Recruiting now

359

Completed

Stopped or withdrawn

Most-studied conditions

Primary Mediastinal Large B-cell Lymphoma (PMBCL) · Indolent B-cell Non-Hodgkin Lymphoma (iNHL) · Non-Muscle Invasive Bladder Neoplasms · Non-small Cell Lung Cancer

Recently updated registry entries

NCT05902169 — Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU… (Recruiting)
NCT07210723 — A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic… (Recruiting)
NCT06476184 — Utility of Adjusting Chemotherapy Dose & Dosing Schedule With the SALVage Weekly… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Erasmus MC ( Site 5303)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.